The Current Ratio as of December 2025 (TTM) for Acumen Pharmaceuticals, Inc. (ABOS) is 6.02

According to Acumen Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.02. This represents a change of -9.04% compared to the average of 6.62 of the last 4 quarters.

Acumen Pharmaceuticals, Inc. (ABOS) Historical Current Ratio (quarterly & annually)

How has ABOS Current Ratio performed in the past?

The mean historical Current Ratio of Acumen Pharmaceuticals, Inc. over the last ten years is 16.58. The current 6.02 Current Ratio has changed 3.53% with respect to the historical average. Over the past ten years (40 quarters), ABOS's Current Ratio was at its highest in in the September 2021 quarter at 137.62. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Acumen Pharmaceuticals, Inc. (ABOS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Acumen Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acumen Pharmaceuticals, Inc. (ABOS) Average Current Ratio

How has ABOS Current Ratio performed in the past?

The current Current Ratio of Acumen Pharmaceuticals, Inc. (ABOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acumen Pharmaceuticals, Inc. (ABOS) Current Ratio vs. Peers

How is ABOS’s Current Ratio compared to its peers?

Acumen Pharmaceuticals, Inc.’s Current Ratio is greater than Inovio Pharmaceuticals, Inc. (1.66), greater than Opus Genetics, Inc. (1.90), greater than Agenus Inc. (0.06), greater than Alector, Inc. (3.76), less than Seer, Inc. (14.25), greater than Seres Therapeutics, Inc. (2.30), less than Fate Therapeutics, Inc. (7.87), greater than VistaGen Therapeutics, Inc. (5.79), greater than Spero Therapeutics, Inc. (3.83), greater than Actuate Therapeutics Inc (2.74),

Build a custom stock screener for Acumen Pharmaceuticals, Inc. (ABOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acumen Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acumen Pharmaceuticals, Inc. (ABOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acumen Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.